Scilex Holding (SCLX) Operating Leases (2021 - 2026)
Scilex Holding (SCLX) posted Operating Leases of $12.5 million for Q2 2026, down 1.4% on a QoQ basis from $12.7 million in Q1 2026, and up 1010.92% year-over-year from $1.1 million in Q2 2025.
Analysis
Scilex Holding (SCLX) Operating Leases (2021 - 2026) Analysis & Trends
Scilex Holding has reported Operating Leases for 6 years, with the latest figure at $12.5 million in Q2 2026.
- On a quarterly basis, Operating Leases rose 1010.92% year-over-year to $12.5 million in Q2 2026; TTM through Jun 2026 was $12.5 million, a 1010.92% increase from a year earlier, with the FY2025 full-year figure at $13.2 million, up 763.49% from the prior year.
- Operating Leases was $12.5 million for Q2 2026 at Scilex Holding, down from $12.7 million in the prior quarter.
- The five-year high for Operating Leases was $13.2 million in Q4 2025, with the low at $461000.0 in Q1 2023.
- Average Operating Leases over 5 years is $3.8 million, with a median of $1.9 million recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Operating Leases plunged 46.44% in 2025, then surged 1010.92% in 2026.
- Over 5 years, Operating Leases stood at $665000.0 in 2022, then surged by 236.39% to $2.2 million in 2023, then sank by 31.92% to $1.5 million in 2024, then surged by 763.49% to $13.2 million in 2025, then slipped by 4.88% to $12.5 million in 2026.
- The last three Operating Leases figures came in at $12.5 million (Q2 2026), $12.7 million (Q1 2026), and $13.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.22 Bn | 620.47 Bn | 17.26 Bn |
| 2 | AbbVie | 446.28 Bn | 439.71 Bn | 12.70 Bn |
| 3 | Merck | 357.56 Bn | 350.42 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.11 Bn | 260.42 Bn | 11.24 Bn |
| 5 | Pfizer | 156.86 Bn | 145.17 Bn | 10.94 Bn |
| 6 | Sanofi | 52.10 Bn | 44.72 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.01 Bn | 43.01 Bn | - |
| 8 | Incyte | 24.82 Bn | 20.28 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.39 Bn | 18.73 Bn | 683.80 Mn |
| 10 | Scilex Holding | 35.87 Mn | -76.92 Mn | 3.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.51 Mn |
| Mar 31, 2026 | 12.69 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 461,000.00 |
| Dec 31, 2022 | 665,000.00 |
| Dec 31, 2021 | 1.15 Mn |